INOVIO Form 4 — Shea Jacqueline Elizabeth (Feb. 26, 2022)

Summary

Jacqueline E. Shea, Chief Operating Officer of INOVIO PHARMACEUTICALS, INC. [ INO ], reports 22,545 Restricted Stock Units vesting on 02/26/2022 from a 67,633-unit award, with the issuer withholding 10,764 shares at $ 3.22 for taxes. New grants that day were a Common Stock Option for 282,300 shares at $ 3.22, expiring 02/26/2032, with 70,575 shares vested on February 26, 2022, and 210,700 Restricted Stock Units scheduled to vest 70,234 shares on February 26, 2023 and 70,233 on each of February 26, 2024 and February 26, 2025. Direct holdings end at 33,373 shares. The signature reads /s/ Jacqueline E. Shea, 03/01/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Shea Jacqueline Elizabeth (Last) (First) (Middle) 660 W. GERMANTOWN PIKE (Street) PLYMOUTH MEETING PA 19462 (City) (State) (Zip) | Shea Jacqueline Elizabeth | (Last) | (First) | (Middle) | 660 W. GERMANTOWN PIKE | PLYMOUTH MEETING | PA | 19462 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol INOVIO PHARMACEUTICALS, INC. [ INO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Operating Officer | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Operating Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 02/26/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 02/26/2022 | M | 22,545 | A | (1) | 44,137 | D
Common Stock | 02/26/2022 | F (2) | 10,764 | D | $ 3.22 | 33,373 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Restricted Stock Unit | (1) | 02/26/2022 | M | 22,545 | (1) | (1) | Common Stock | 22,545 | $ 0 (1) | 45,088 | D
Common Stock Option | $ 3.22 | 02/26/2022 | A | 282,300 | 02/26/2022 (3) | 02/26/2032 | Common Stock | 282,300 | $ 0 | 282,300 | D
Restricted Stock Unit | (4) | 02/26/2022 | A | 210,700 | (4) | (4) | Common Stock | 210,700 | $ 0 (4) | 210,700 | D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
3. The vesting schedule for the 282,300 options is as follows: 70,575 shares vested on February 26, 2022; 70,575 shares will vest on February 26, 2023; 70,575 shares will vest on February 26, 2024; 70,575 shares will vest on February 26, 2025.
4. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Remarks:
/s/ Jacqueline E. Shea | 03/01/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_INO_4_filed2022-03-01_0001055726-22-000010.xml

Size

20,270 bytes

SHA-256

b4651da42088d86253e6d9e110486fb3e8f464ef0e4a3d40d583f684809ce2ae

Our copy

SEC_INO_4_filed2022-03-01_0001055726-22-000010.xml

Original

www.sec.gov